| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 115.901 | 94.572 | 137.428 | 168.583 | 169.068 | 181.036 | 254.973 | 287.843 | 248.241 | 239.092 |
| Total Income - EUR | 116.591 | 94.752 | 137.467 | 168.723 | 171.691 | 184.691 | 254.973 | 287.843 | 248.241 | 239.113 |
| Total Expenses - EUR | 92.148 | 93.000 | 129.217 | 152.177 | 156.717 | 148.066 | 188.056 | 187.097 | 159.089 | 165.710 |
| Gross Profit/Loss - EUR | 24.443 | 1.752 | 8.250 | 16.546 | 14.974 | 36.625 | 66.917 | 100.746 | 89.152 | 73.403 |
| Net Profit/Loss - EUR | 19.683 | 803 | 5.668 | 14.858 | 13.257 | 34.779 | 64.367 | 97.868 | 86.669 | 66.230 |
| Employees | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 9 | 10 |
Check the financial reports for the company - Centromedicor S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 54.894 | 81.036 | 67.721 | 97.290 | 144.103 | 387.082 | 357.951 | 370.941 | 356.582 | 333.892 |
| Current Assets | 5.588 | 15.273 | 15.611 | 39.838 | 47.122 | 3.322 | 35.456 | 2.460 | 38.768 | 8.565 |
| Inventories | 0 | 12.454 | 8.073 | 7.925 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.409 | 128 | 6.374 | 30.009 | 94 | 609 | 2.411 | 435 | 926 | 856 |
| Cash | 4.179 | 2.690 | 1.164 | 1.904 | 47.028 | 2.714 | 33.044 | 2.025 | 37.842 | 7.708 |
| Shareholders Funds | 46.065 | 46.398 | 51.281 | 65.198 | 77.193 | 110.508 | 172.425 | 270.828 | 356.676 | 326.951 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 14.417 | 53.852 | 32.051 | 71.930 | 114.032 | 279.896 | 220.982 | 102.574 | 38.674 | 15.506 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Centromedicor S.r.l.